Leukemia & Lymphoma, Volume 60, Issue 13 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 60, Issue 13 (2019)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Volume 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Impact of myosteatosis in survivors of childhood acute lymphoblastic leukemia
Jenna Rossoff & Leonidas C. Platanias
Pages: 3097-3098
Published online: 21 Jun 2019
CitationforImpact of myosteatosis in survivors of childhood acute lymphoblastic leukemia | Full Text | References | PDF (366.2 KB) | EPUB
  • 83 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
The role of ponatinib in chronic myeloid leukemia in the era of treatment free remission
Claire Andrews & Jeffrey Lipton
Pages: 3099-3101
Published online: 26 Sep 2019
First Page PreviewforThe role of ponatinib in chronic myeloid leukemia in the era of treatment free remission | Full Text | References | PDF (296.4 KB) | EPUB
  • 230 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
Banking on a cooperative effort
Stephen S. Chung
Pages: 3102-3103
Published online: 21 Aug 2019
CitationforBanking on a cooperative effort | Full Text | References | PDF (235.7 KB) | EPUB
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Chronic lymphocytic leukemia, skin and other second cancers
Stephen P. Mulligan, Stephen Shumack & Alexander Guminski
Pages: 3104-3106
Published online: 24 Sep 2019
First Page PreviewforChronic lymphocytic leukemia, skin and other second cancers | Full Text | References | PDF (307.9 KB) | EPUB
  • 312 Views
  • 7 CrossRef citations
  • 0Altmetric

Reviews

Review
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Maximilian Stahl & Martin S. Tallman
Pages: 3107-3115
Published online: 16 Dec 2019
AbstractforAcute promyelocytic leukemia (APL): remaining challenges towards a cure for all | Full Text | References | PDF (844.8 KB) | EPUB
  • 1569 Views
  • 44 CrossRef citations
  • 0Altmetric
Review
Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review
Rakel Pálmarsdóttir, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, Ingrid Glimelius, Karin E. Smedby & Tarec El-Galaly
Pages: 3116-3131
Published online: 06 Jun 2019
AbstractforSocioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review | Full Text | References | PDF (1.3 MB) | EPUB
  • 408 Views
  • 12 CrossRef citations
  • 0Altmetric

Original Articles

Article
Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions
Timothy G. Bowler, Kith Pradhan, Yu Kong, Matthias Bartenstein, Kerry A. Morrone, Ashwin Sridharan, Rachel M. Kessel, Aditi Shastri, Orsi Giricz, Tushar D. Bhagat, Shanisha Gordon-Mitchell, Mersedeh Rohanizadegan, Lauren Hooda, Ishan Datt, Bartlomiej P. Przychodzen, Simrit Parmar, Shahina Maqbool, Jaroslaw P. Maciejewski, Ulrich Steidl, John M. Greally & Amit Verma
Pages: 3132-3137
Published online: 10 Jul 2019
AbstractforMisidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 526 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Clinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia
Borahm Kim, Hyeonah Lee, Esl Kim, Saeam Shin, Seung-Tae Lee & Jong Rak Choi
Pages: 3138-3145
Published online: 17 Jun 2019
AbstractforClinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 476 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Myosteatosis in adolescents and young adults treated for acute lymphoblastic leukemia
Nicole M. Mueske, Steven D. Mittelman, Tishya A. L. Wren, Vicente Gilsanz & Etan Orgel
Pages: 3146-3153
Published online: 02 Jul 2019
AbstractforMyosteatosis in adolescents and young adults treated for acute lymphoblastic leukemia | Full Text | References | PDF (812.5 KB) | EPUB
  • 362 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy era
B. K. Karthik Bommannan, Jhansi Rani Arumugam, Shirley Sundersingh, Priya T. Rajan, Venkatraman Radhakrishnan & Tenali Gnana Sagar
Pages: 3154-3160
Published online: 11 Jun 2019
AbstractforCD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy era | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 323 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
Mikkael A. Sekeres, Steven D. Gore, Donald M. Stablein, Nancy DiFronzo, Gregory A. Abel, Amy E. DeZern, Jesse D. Troy, Dana E. Rollison, John W. Thomas, Myron A. Waclawiw, Jane Jijun Liu, Tareq Al Baghdadi, Matthew J. Walter, Rafael Bejar, Edward J. Gorak, Daniel T. Starczynowski, James M. Foran, James R. Cerhan, Lynn C. Moscinski, Rami S. Komrokji, H. Joachim Deeg & Pearlie K. Epling-Burnette
Pages: 3161-3171
Published online: 21 May 2019
AbstractforThe National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 695 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, Srdan Verstovsek, Guillermo Garcia-Manero, Naval Daver, Tapan Kadia, Farhad Ravandi, Elias Jabbour, Jorge Cortes & Hagop Kantarjian
Pages: 3172-3180
Published online: 24 May 2019
AbstractforOutcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy | Full Text | References | PDF (1.5 MB) | EPUB
  • 286 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis
Amer M. Zeidan, Weiwei Zhu, Maximilian Stahl, Rong Wang, Scott F. Huntington, Smith Giri, Nikolai A. Podoltsev, Steven D. Gore, Xiaomei Ma & Amy J. Davidoff
Pages: 3181-3187
Published online: 07 Jun 2019
AbstractforRBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 298 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Epigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma
Jing Qi, Lin-Ying Shi, Yin Wu, Xian-Juan Shen, Jie Yuan, Chun-Jing Jin, Hui Cong & Shao-Qing Ju
Pages: 3188-3198
Published online: 13 Jun 2019
AbstractforEpigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma | Full Text | References | PDF (2.8 MB) | EPUB
  • 143 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center
Patrick Yau, Victor H. Jimenez-Zepeda, Kyla Bailey, Peter Duggan, Jason Tay, Nizar J. Bahlis, Paola Neri & Sylvia McCulloch
Pages: 3199-3203
Published online: 13 Jun 2019
AbstractforSlow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center | Full Text | References | PDF (429.8 KB) | EPUB
  • 820 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival
Ganchimeg Ishdorj, Sara Beiggi, Zoann Nugent, Erin Streu, Versha Banerji, Dhali Dhaliwal, Salah M. Mahmud, Aaron J. Marshall, Spencer B. Gibson, Marni C. Wiseman & James B. Johnston
Pages: 3204-3213
Published online: 25 Jun 2019
AbstractforRisk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival | Full Text | References | PDF (1 MB) | EPUB
  • 508 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma
Ming Liang Oon, Michal M. Hoppe, Shuangyi Fan, The Phyu, Hoang M. Phuong, Soo-Yong Tan, Susan Swee-Shan Hue, Shi Wang, Li M. Poon, Hian L. E. Chan, Joanne Lee, Yen L. Chee, Wee-Joo Chng, Sanjay de Mel, Xin Liu, Anand D. Jeyasekharan & Siok-Bian Ng
Pages: 3214-3224
Published online: 01 Jul 2019
AbstractforThe contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma | Full Text | References | PDF (2.5 MB) | EPUB
  • 245 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Insurance status impacts overall survival in Burkitt lymphoma
Jordan S. Goldstein, Jeffrey M. Switchenko, Madhusmita Behera, Christopher R. Flowers & Jean L. Koff
Pages: 3225-3234
Published online: 05 Jul 2019
AbstractforInsurance status impacts overall survival in Burkitt lymphoma | Full Text | References | PDF (1.3 MB) | EPUB
  • 216 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database
Jaime Shaw, Christopher Harvey, Catherine Richards & Christopher Kim
Pages: 3235-3243
Published online: 12 Jun 2019
AbstractforTemporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 3720 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Article
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma
Christian Baues, Helen Görgen, Robert Semrau, Beatrix Nast-Kolb, Katja Assenmacher, Eren Celik, Janis Morgenthaler, Johannes Rosenbrock, Maike Trommer, Christian Houbois, Carsten Kobe, Jan Kriz, Andreas Engert & Simone Marnitz
Pages: 3244-3250
Published online: 22 Jun 2019
AbstractforVolumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma | Full Text | References | PDF (992.9 KB) | EPUB
  • 146 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)
Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Jung Yong Hong, Deok-Hwan Yang, Won Sik Lee, Young Rok Do, Young Il Koh, Jong-Ho Won, Min Kyoung Kim, Jae-Cheol Jo, Shin Young Hyun, Jeong-A Kim, Young Ha Oh & Seung-Sook Lee
Pages: 3251-3257
Published online: 06 Jun 2019
AbstractforA phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial) | Full Text | References | PDF (2.2 MB) | EPUB
  • 388 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma
Therese Y. Andraos, Zeina Ayoub, Loretta J Nastoupil, Sarah A. Milgrom, Chelsea C. Pinnix, Sweet Ping Ng, Jillian R. Gunther, Nathan H. Fowler, Sattva S. Neelapu, Felipe Samaniego, Luis E. Fayad & Bouthaina S. Dabaja
Pages: 3258-3265
Published online: 24 Jun 2019
AbstractforAdditional therapy improves outcomes in completely resected, limited-stage follicular lymphoma | Full Text | References | PDF (1 MB) | EPUB
  • 281 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status
Amir Behdad, Craig S. Boddy, Angela J. Fought, Timothy Taxter, Marissa K. Falkiewicz, Emily Ayers, Qing C. Chen, Yi-Hua Chen, Reem Karmali, Barbara Pro, Jane N. Winter, Daniel J. Landsburg, Leo I. Gordon & Jason B. Kaplan
Pages: 3266-3271
Published online: 21 Jun 2019
AbstractforSurvival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status | Full Text | References | PDF (642.8 KB) | EPUB
  • 453 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma – implications for staging
Ana Acuna-Villaorduna, Jesus Gonzalez-Lugo, B. Hilda Ye, Diego Andres Adrianzen Herrera, R Alejandro Sica, Urvi Shah, Nishi Shah, Noah Kornblum, Ira Braunschweig, Olga Derman, Ioannis Mantzaris, Aditi Shastri, Yanhua Wang, Amit Verma, Benjamin Zalta & Murali Janakiram
Pages: 3272-3276
Published online: 17 Jun 2019
AbstractforHigh prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma – implications for staging | Full Text | References | PDF (1.3 MB) | EPUB
  • 198 Views
  • 3 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigma
Eleftheria Lamprianidou, Emmanouela Zoulia, Elsa Bernard, Chryssoula Kordella, Menelaos Papoutselis, Zoi Bezirgiannidou, George Vrachiolias, Elli Papaemmanuil & Ioannis Kotsianidis
Pages: 3277-3281
Published online: 12 Jun 2019
First Page PreviewforMultifaceted modes of action of azacytidine: a riddle wrapped up in an enigma | Full Text | References | PDF (628.6 KB) | EPUB | Supplemental
  • 181 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study
Candace L. Haddox, Ryan M. Carr, Roshini S. Abraham, Juliana Perez Botero, Vilmarie Rodriguez, Animesh Pardanani & Mrinal M. Patnaik
Pages: 3282-3286
Published online: 27 Jun 2019
First Page PreviewforPhenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study | Full Text | References | PDF (1 MB) | EPUB
  • 308 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Anisocytosis is a poor prognostic factor in secondary polycythemia
Jose N. Galeas, Nilupa Gaspe, Kith Pradhan, Hernando Cordero, Amit Verma & Swati Goel
Pages: 3287-3291
Published online: 13 Jun 2019
First Page PreviewforAnisocytosis is a poor prognostic factor in secondary polycythemia | Full Text | References | PDF (745.3 KB) | EPUB | Supplemental
  • 100 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series
Hind Rafei, Elias Joseph Jabbour, Hagop Kantarjian, Kaylyn D. Sinicrope, Carlos Kamiya-Matsuoka, Rohtesh S. Mehta, Naval G. Daver, Tapan M. Kadia, Kiran Naqvi, Jorge Cortes & Marina Konopleva
Pages: 3292-3295
Published online: 27 Jun 2019
First Page PreviewforNeurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series | Full Text | References | PDF (548.1 KB) | EPUB
  • 452 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy
Morten Orebo Holmström, Guy W. Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H. Andersen, Signe Ledou Nielsen, Daniel El Fassi & Claudia Schöllkopf
Pages: 3296-3299
Published online: 01 Jul 2019
First Page PreviewforProgression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 264 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature
Helen Ma, Govind Bhagat & Owen A. O'Connor
Pages: 3300-3303
Published online: 11 Jun 2019
First Page PreviewforA peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature | Full Text | References | PDF (1.3 MB) | EPUB
  • 330 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene
Fujue Wang, Yingying Chen, Nenggang Jiang, Shuaige Gong, Tingyong Cao, Jin Yuan, Jiazhuo Liu, Liping Xie, Yu Wu & Yongqian Jia
Pages: 3304-3307
Published online: 01 Jul 2019
First Page PreviewforAcquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene | Full Text | References | PDF (670.4 KB) | EPUB
  • 147 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation – a single institution pilot study
Richard J. Lin, Parastoo B. Dahi, Armin Shahrokni, Saman Sarraf, Beatriz Korc-Grodzicki, Sean M. Devlin, Molly A. Maloy, Gunjan L. Shah, Ann A. Jakubowski & Sergio A. Giralt
Pages: 3308-3311
Published online: 21 Jun 2019
First Page PreviewforFeasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation – a single institution pilot study | Full Text | References | PDF (498.2 KB) | EPUB
  • 265 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome
Scott A. Turner, Aaron C. Shaver, Alexandra E. Kovach, Olalekan O. Oluwole & Emily F. Mason
Pages: 3312-3315
Published online: 22 Jun 2019
First Page PreviewforMyelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome | Full Text | References | PDF (1.1 MB) | EPUB
  • 173 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 – azacitidine induces only lymphoma remission
Magnus Tobiasson, Tatjana Pandzic, Lucia Cavelier, Birgitta Sander & Björn Engelbrekt Wahlin
Pages: 3316-3319
Published online: 17 Jun 2019
First Page PreviewforAngioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 – azacitidine induces only lymphoma remission | Full Text | References | PDF (1.3 MB) | EPUB
  • 495 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma
Milos D. Miljkovic, Mark Roschewski, Kieron Dunleavy & Wyndham H. Wilson
Pages: 3320-3323
Published online: 17 Jun 2019
First Page PreviewforHybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma | Full Text | References | PDF (446.4 KB) | EPUB
  • 201 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab
Mireia Franch-Sarto, Marc Sorigue, Laia López, Miriam Moreno, Josep-Maria Ribera & Juan-Manuel Sancho
Pages: 3324-3326
Published online: 15 Oct 2018
First Page PreviewforOverall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab | Full Text | References | PDF (452 KB) | EPUB | Supplemental
  • 234 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia
Loïc Vasseur, Diane Lara, Emmanuelle Clappier, Quentin Gillebert, Claire Glaser, Solene Houlle-Crepin, Nicolas Ortonne, Elsa Poullot, Philippe Rousselot & Caroline Besson
Pages: 3327-3329
Published online: 11 Jun 2019
First Page PreviewforCommon clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia | Full Text | References | PDF (869.2 KB) | EPUB
  • 157 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia
Matteo Dragani, Giovanna Rege-Cambrin, Dario Ferrero, Elisabetta Abruzzese, Patrizia Pregno, Chiara Elena, Michele Cedrone, Marco Santoro, Giacomo Andreani, Giuseppe Saglio & Carmen Fava
Pages: 3330-3332
Published online: 04 Jun 2019
First Page PreviewforBeyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia | Full Text | References | PDF (404.2 KB) | EPUB
  • 163 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients
George Nesr, Simone Claudiani, Jamshid Khorashad, Jane Apperley & Dragana Milojkovic
Pages: 3333-3334
Published online: 22 Jun 2019
CitationforThe influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients | Full Text | References | PDF (347.7 KB) | EPUB
  • 111 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Strong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia – a prominent biomarker and potential target for anti-SLAMF7 antibody therapy
Ahmet H. Elmaagacli, Hans Salwender, Christian Jehn, Farouk Dahmash, Anju Singh, Oliver Wilson, Marc Pannenbeckers, Cornelius Niggemann & Mathias Vierbuchen
Pages: 3335-3338
Published online: 04 Jun 2019
First Page PreviewforStrong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia – a prominent biomarker and potential target for anti-SLAMF7 antibody therapy | Full Text | References | PDF (762.1 KB) | EPUB | Supplemental
  • 257 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
FLAI induction regimen in elderly patients with acute myeloid leukemia
Marco Cerrano, Anna Candoni, Elena Crisà, Maria Vittoria Dubbini, Stefano D’Ardia, Maria Elena Zannier, Mario Boccadoro, Ernesta Audisio, Benedetto Bruno & Dario Ferrero
Pages: 3339-3340
Published online: 04 Jun 2019
CitationforFLAI induction regimen in elderly patients with acute myeloid leukemia | Full Text | References | PDF (383.2 KB) | EPUB
  • 135 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Plesiomonas shigelloides gastroenteritis in a patient with chronic lymphocytic leukemia
Mansour Alfayez, Jan A. Burger, Tapan Kadia, Teena H. Xu, Ariel D. Szvalb & Naveen Pemmaraju
Pages: 3341-3342
Published online: 15 Jul 2019
CitationforPlesiomonas shigelloides gastroenteritis in a patient with chronic lymphocytic leukemia | Full Text | References | PDF (241.6 KB) | EPUB
  • 137 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles